1. Home
  2. RGEN vs FAF Comparison

RGEN vs FAF Comparison

Compare RGEN & FAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • FAF
  • Stock Information
  • Founded
  • RGEN 1981
  • FAF 1889
  • Country
  • RGEN United States
  • FAF United States
  • Employees
  • RGEN N/A
  • FAF N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • FAF Specialty Insurers
  • Sector
  • RGEN Health Care
  • FAF Finance
  • Exchange
  • RGEN Nasdaq
  • FAF Nasdaq
  • Market Cap
  • RGEN 8.2B
  • FAF 5.9B
  • IPO Year
  • RGEN N/A
  • FAF N/A
  • Fundamental
  • Price
  • RGEN $142.14
  • FAF $67.21
  • Analyst Decision
  • RGEN Buy
  • FAF Buy
  • Analyst Count
  • RGEN 10
  • FAF 5
  • Target Price
  • RGEN $190.25
  • FAF $65.80
  • AVG Volume (30 Days)
  • RGEN 558.2K
  • FAF 760.8K
  • Earning Date
  • RGEN 10-29-2024
  • FAF 10-23-2024
  • Dividend Yield
  • RGEN N/A
  • FAF 3.21%
  • EPS Growth
  • RGEN N/A
  • FAF N/A
  • EPS
  • RGEN N/A
  • FAF 1.87
  • Revenue
  • RGEN $602,354,000.00
  • FAF $5,947,400,000.00
  • Revenue This Year
  • RGEN $0.35
  • FAF N/A
  • Revenue Next Year
  • RGEN $12.36
  • FAF $8.57
  • P/E Ratio
  • RGEN N/A
  • FAF $35.96
  • Revenue Growth
  • RGEN N/A
  • FAF N/A
  • 52 Week Low
  • RGEN $110.45
  • FAF $49.55
  • 52 Week High
  • RGEN $211.13
  • FAF $67.88
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 50.54
  • FAF 62.88
  • Support Level
  • RGEN $136.94
  • FAF $62.83
  • Resistance Level
  • RGEN $147.35
  • FAF $64.64
  • Average True Range (ATR)
  • RGEN 5.38
  • FAF 1.27
  • MACD
  • RGEN 0.45
  • FAF 0.18
  • Stochastic Oscillator
  • RGEN 42.37
  • FAF 89.21

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About FAF First American Corporation (New)

First American Financial Corp is a financial services business providing insurance through two segments: title insurance and related services and Home warranty. Title insurance and related services include real estate insurance, property closing services, third-party handling of real estate funds (escrow), risk mitigation, real estate data products, and related real estate transaction services. The home warranty segment provides residential service contracts that cover residential systems, such as heating and air conditioning systems, and certain appliances against failures that occur as the result of normal usage during the coverage period. Nearly all the company's revenue comes from the title insurance and related services segment in the United States.

Share on Social Networks: